About 41,100 results
Open links in new tab
  1. AstraZeneca | Cafepharma

    4 days ago · AstraZeneca’s investigational ATR kinase inhibitor did not improve overall survival when combined with Imfinzi in patients with non-small cell lung cancer during a Phase III clinical trial, the …

  2. baxdrostat | Cafepharma

    Dec 3, 2025 · AstraZeneca's baxdrostat has hit the mark in another phase 3 trial involving people who struggle to control their blood pressure with current therapies, keeping the would-be blockbuster on …

  3. Imfinzi | Cafepharma

    Nov 26, 2025 · The FDA has recently approved AstraZeneca’s Imfinzi (durvalumab) for perioperative use in cisplatin-eligible muscle-invasive bladder cancer (MIBC), based on the Phase III NIAGARA …

  4. Saphnelo | Cafepharma

    4 days ago · AstraZeneca’s fully human monoclonal antibody, Saphnelo (anifrolumab) subcutaneous (SC) administration has shown a decrease in disease activity in individuals with systemic lupus …

  5. light chain amyloidosis | Cafepharma

    Dec 4, 2025 · Almost four years after penning its first amyloidosis collaboration with Neurimmune, AstraZeneca has returned to pick up a second asset. The latest licensing deal involves NI009, a …

  6. Caprelsa | Cafepharma

    Aug 23, 2023 · Caprelsa AstraZeneca sells rare cancer drug to Sanofi for up to $300 million Submitted by admin on Mon, 07/27/2015 - 10:00 Read more about AstraZeneca sells rare cancer drug to Sanofi …

  7. Fasenra | Cafepharma

    Nov 9, 2025 · AstraZeneca's Fasenra (benralizumab) has recently been approved by the FDA for treating severe asthma in children aged 6 to 11 with the eosinophilic phenotype. A phase III clinical …

  8. AstraZeneca | Cafepharma Message Boards | Pharma Sales, Device …

    Jun 13, 2025 · Anonymous board for AstraZeneca.We’ve seen a growing number of threads touching on AI tools—everything from ChatGPT to internal company initiatives—but mostly in bits and pieces. …

  9. Airsupra | Cafepharma

    Sep 26, 2025 · AstraZeneca is the latest Big Pharma to unveil a digital direct-to-consumer platform offering certain medicines at heavily reduced prices to cash-pay patients. AstraZeneca Direct will go …

  10. July 24 2025 - AstraZeneca drug acquired in Alexion deal succeeds in ...

    Jul 24, 2025 · AstraZeneca drug acquired in Alexion deal succeeds in autoimmune disease trialAstraZeneca boardPharma giant Roche sees income soar in first halfRoche boardNovartis to pay …